
5.24 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 4.95 Today|||52-Week Range 12.79 | -13.10% Year-to-Date |
The 6 analysts offering 12-month price forecasts for CureVac NV have a median target of 14.88, with a high estimate of 20.86 and a low estimate of 7.87. The median estimate represents a +184.00% increase from the last price of 5.24.
The current consensus among 8 polled investment analysts is to Buy stock in CureVac NV. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.